After Hours Decliner
KOD Kodiak Sciences23.02-0.79-3.3%
After Hours:21.50-1.52 (-6.6%)
Kodiak Sciences Announces Proposed Public Offering of Common Stock
PRNewswireMon, 15-Dec 4:01 PM
KOD Kodiak Sciences16.04+0.55 (+3.6%)
KOD Kodiak Sciences3.56-3.73 (-51.2%)
Premarket Decliner
KOD Kodiak Sciences7.29+0.21+3.0%
Premarket:3.87-3.42 (-46.9%)
Kodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Provides Update on Tarcocimab Development Program
PRNewswireMon, 24-Jul 6:00 AM
KOD Kodiak Sciences7.25-0.94 (-11.5%)
KOD Kodiak Sciences9.44+0.20 (+2.2%)
